Federal contract award
75N90025P00693
NBM-200 NON-INVASIVE HEMOGLOBIN MONITORING DEVICES (R) ORSENSE U.S., LLC:1613665 [25-007884]
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH - CC |
| NAICS | 334510 — Electromedical and Electrotherapeutic Apparatus Manufacturing |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $18.0K |
| Current contract value | $18.0K |
| Potential contract value / ceiling | $18.0K |
| Start date | Sep 9, 2025 |
| Current end date | Sep 30, 2025 |
| Potential end date | Oct 9, 2025 |
| Latest award activity | Sep 9, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 9, 2025 | 0 | $18.0K | NBM-200 NON-INVASIVE HEMOGLOBIN MONITORING DEVICES (R) ORSENSE U.S., LLC:1613665 [25-007884] |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.